M E Pfisterer

Summary

Affiliation: University Hospital
Country: Switzerland

Publications

  1. ncbi request reprint Prevention of supraventricular tachyarrhythmias after open heart operation by low-dose sotalol: a prospective, double-blind, randomized, placebo-controlled study
    M E Pfisterer
    Department of Internal Medicine, and Clinic for Cardiothoracic Surgery, University Hospital, Basel, Switzerland
    Ann Thorac Surg 64:1113-9. 1997
  2. ncbi request reprint Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents
    Matthias Pfisterer
    Department of Cardiology, University Hospital, Basel, Switzerland
    J Am Coll Cardiol 48:2584-91. 2006
  3. ncbi request reprint Long-term outcome in elderly patients with chronic angina managed invasively versus by optimized medical therapy: four-year follow-up of the randomized Trial of Invasive versus Medical therapy in Elderly patients (TIME)
    Matthias Pfisterer
    Department of Cardiology, University Hospital, Basel, Switzerland
    Circulation 110:1213-8. 2004
  4. doi request reprint Long-term benefit-risk balance of drug-eluting vs. bare-metal stents in daily practice: does stent diameter matter? Three-year follow-up of BASKET
    Matthias Pfisterer
    Department of Cardiology, University Hospital Basel, Petersgraben, Basel, Switzerland
    Eur Heart J 30:16-24. 2009
  5. doi request reprint Improvements in physical and mental domains of quality of life by anti-ischaemic drug and revascularisation treatment in elderly men and women with chronic angina
    M A Buser
    Department of Cardiology, University Hospital, Basel, Switzerland
    Heart 94:1413-8. 2008
  6. doi request reprint Drug-eluting or bare-metal stents for large coronary vessel stenting? The BASKET-PROVE (PROspective Validation Examination) trial: study protocol and design
    Matthias Pfisterer
    Department of Cardiology, University Hospital Basel, Basel, Switzerland
    Am Heart J 155:609-14. 2008
  7. doi request reprint BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial
    Matthias Pfisterer
    Department of Cardiology, University Hospital Basel, CH 4031 Basel, Switzerland
    JAMA 301:383-92. 2009
  8. ncbi request reprint Right ventricular involvement in myocardial infarction and cardiogenic shock
    Matthias Pfisterer
    Division of Cardiology, University Hospital, CH 4031, Basel, Switzerland
    Lancet 362:392-4. 2003
  9. ncbi request reprint Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy: one-year results of the randomized TIME trial
    Matthias Pfisterer
    Department of Cardiology, University Hospital, Petersgraben 4, CH 4031 Basel, Switzerland
    JAMA 289:1117-23. 2003
  10. ncbi request reprint Time dependence of left ventricular recovery after delayed recanalization of an occluded infarct-related coronary artery: findings of a pilot study
    M E Pfisterer
    Department of Internal Medicine, University Hospital, Basel, Switzerland
    J Am Coll Cardiol 32:97-102. 1998

Detail Information

Publications49

  1. ncbi request reprint Prevention of supraventricular tachyarrhythmias after open heart operation by low-dose sotalol: a prospective, double-blind, randomized, placebo-controlled study
    M E Pfisterer
    Department of Internal Medicine, and Clinic for Cardiothoracic Surgery, University Hospital, Basel, Switzerland
    Ann Thorac Surg 64:1113-9. 1997
    ..The aim of this prospective, double-blind, placebo-controlled trial was to assess the preventive effect and safety of low-dose sotalol after heart operation...
  2. ncbi request reprint Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents
    Matthias Pfisterer
    Department of Cardiology, University Hospital, Basel, Switzerland
    J Am Coll Cardiol 48:2584-91. 2006
    ..We sought to define the incidence of late clinical events and late stent thrombosis in patients treated with drug-eluting (DES) versus bare-metal stents (BMS) after the discontinuation of clopidogrel as well as their timing and outcome...
  3. ncbi request reprint Long-term outcome in elderly patients with chronic angina managed invasively versus by optimized medical therapy: four-year follow-up of the randomized Trial of Invasive versus Medical therapy in Elderly patients (TIME)
    Matthias Pfisterer
    Department of Cardiology, University Hospital, Basel, Switzerland
    Circulation 110:1213-8. 2004
    ..There are no prospective trial data on long-term outcomes in 80-year-old patients with chronic angina with regard to antiischemic therapy...
  4. doi request reprint Long-term benefit-risk balance of drug-eluting vs. bare-metal stents in daily practice: does stent diameter matter? Three-year follow-up of BASKET
    Matthias Pfisterer
    Department of Cardiology, University Hospital Basel, Petersgraben, Basel, Switzerland
    Eur Heart J 30:16-24. 2009
    ..To assess the long-term benefit-risk ratio of drug-eluting (DES) vs. bare-metal stents (BMS) relative to stent size...
  5. doi request reprint Improvements in physical and mental domains of quality of life by anti-ischaemic drug and revascularisation treatment in elderly men and women with chronic angina
    M A Buser
    Department of Cardiology, University Hospital, Basel, Switzerland
    Heart 94:1413-8. 2008
    ..It is not known, however, whether improvements relate only to physical or also to mental and social domains of QoL and whether women benefit in a similar way to men...
  6. doi request reprint Drug-eluting or bare-metal stents for large coronary vessel stenting? The BASKET-PROVE (PROspective Validation Examination) trial: study protocol and design
    Matthias Pfisterer
    Department of Cardiology, University Hospital Basel, Basel, Switzerland
    Am Heart J 155:609-14. 2008
    ....
  7. doi request reprint BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial
    Matthias Pfisterer
    Department of Cardiology, University Hospital Basel, CH 4031 Basel, Switzerland
    JAMA 301:383-92. 2009
    ..It is uncertain whether intensified heart failure therapy guided by N-terminal brain natriuretic peptide (BNP) is superior to symptom-guided therapy...
  8. ncbi request reprint Right ventricular involvement in myocardial infarction and cardiogenic shock
    Matthias Pfisterer
    Division of Cardiology, University Hospital, CH 4031, Basel, Switzerland
    Lancet 362:392-4. 2003
    ..Right ventricular shock has important therapeutic implications for the management of patients, which need to be recognised...
  9. ncbi request reprint Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy: one-year results of the randomized TIME trial
    Matthias Pfisterer
    Department of Cardiology, University Hospital, Petersgraben 4, CH 4031 Basel, Switzerland
    JAMA 289:1117-23. 2003
    ..The Trial of Invasive versus Medical therapy in Elderly patients (TIME) recently showed early benefits in quality of life from invasive therapy in patients aged 75 years or older, although with a certain excess in mortality...
  10. ncbi request reprint Time dependence of left ventricular recovery after delayed recanalization of an occluded infarct-related coronary artery: findings of a pilot study
    M E Pfisterer
    Department of Internal Medicine, University Hospital, Basel, Switzerland
    J Am Coll Cardiol 32:97-102. 1998
    ..We sought to test the hypothesis that late recanalization of infarct-related coronary arteries (IRAs) improves long-term left ventricular (LV) function...
  11. ncbi request reprint Long-term outcome of angioplasty for multivessel coronary disease: importance and price of complete revascularization
    U C Kloeter
    Division of Cardiology, Department of Internal Medicine, University Hospital, Basel, Switzerland
    Int J Cardiol 79:197-205. 2001
    ..CONCLUSION: MVD angioplasty with complete revascularization has a long-term event-free survival similar to that of SVD angioplasty but at the price of a higher rate of 6-month restenosis and repeat interventions...
  12. doi request reprint Combined clopidogrel and proton pump inhibitor therapy is associated with higher cardiovascular event rates after percutaneous coronary intervention: a report from the BASKET trial
    T Burkard
    Cardiology, University Hospital, Basel, Switzerland
    J Intern Med 271:257-63. 2012
    ..To investigate whether there is an increased risk of cardiac events with a combined therapy of clopidogrel and proton pump inhibitors (PPIs) after percutaneous coronary intervention (PCI)...
  13. ncbi request reprint Primary PCI in STEMI--dilemmas and controversies: multivessel disease in STEMI patients. Complete versus Culprit Vessel revascularization in acute ST--elevation myocardial infarction
    R V Jeger
    Department of Cardiology, University Hospital Basel, Basel, Switzerland
    Minerva Cardioangiol 59:225-33. 2011
    ..It should be considered whether current guidelines should be changed to account for these considerations, and other adequately powered randomized controlled trials should be performed to endorse current knowledge...
  14. ncbi request reprint Management of elderly patients with congestive heart failure--design of the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF)
    Hans Peter Brunner-La Rocca
    Division of Cardiology, University Hospital Basel, Basel, Switzerland
    Am Heart J 151:949-55. 2006
    ....
  15. ncbi request reprint Elevated troponin levels in absence of coronary artery disease after supraventricular tachycardia
    M J Zellweger
    Cardiology Department, University Hospital, Basel, Switzerland
    Swiss Med Wkly 133:439-41. 2003
    ..Four patients with elevated troponin levels after supraventricular tachycardia without evidence of coronary artery disease and very low risk scores for acute coronary syndrome are described and discussed...
  16. ncbi request reprint Cost-effectiveness of invasive versus medical management of elderly patients with chronic symptomatic coronary artery disease. Findings of the randomized trial of invasive versus medical therapy in elderly patients with chronic angina (TIME)
    Jacques Claude
    Division of Cardiology, University Hospital, CH 4031 Basel, Switzerland
    Eur Heart J 25:2195-203. 2004
    ..To compare benefits and costs of invasive versus medical management in elderly patients with chronic angina...
  17. ncbi request reprint Risks and benefits of optimised medical and revascularisation therapy in elderly patients with angina--on-treatment analysis of the TIME trial
    Christoph Kaiser
    Department of Cardiology, University Hospitals Basel, Petersgraben 4, 4031 Basel, Switzerland
    Eur Heart J 25:1036-42. 2004
    ..To assess treatment effects of optimised medical therapy and PCI or CABG surgery on one-year outcome in patients 75 years old with chronic angina...
  18. ncbi request reprint Comparison of presentation, perception, and six-month outcome between women and men > or =75 years of age with angina pectoris
    Gabriela M Kuster
    University Hospital, Basel, Switzerland
    Am J Cardiol 91:436-9. 2003
  19. ncbi request reprint Stunning and left ventricular function--how long is the ventricle knocked out? Left ventricular function correlated with ischemic burden and recovery time after stress
    B A Kaufmann
    Department of Cardiology, University Hospital, Basel, Switzerland
    Int J Cardiol 112:223-8. 2006
    ..Little is known about the relation between severity of ischemia and duration of myocardial stunning. The aim of this study was therefore to characterize the impact of ischemia on myocardial stunning and on its duration...
  20. ncbi request reprint Drug treatment of chronic heart failure in the elderly
    Gregor Leibundgut
    Cardiology, University Hospital Basel, Basel, Switzerland
    Drugs Aging 24:991-1006. 2007
    ....
  21. ncbi request reprint Targeted stent use in clinical practice based on evidence from the Basel Stent Cost Effectiveness Trial (BASKET)
    Hans Peter Brunner-La Rocca
    Division of Cardiology, University Hospital Basel, Switzerland
    Eur Heart J 28:719-25. 2007
    ..It is unknown which patients benefit most from drug-eluting stents (DES) against bare-metal stents (BMS) in a long-term clinical outcome...
  22. ncbi request reprint Early and late increased bleeding rates after angioplasty and stenting due to combined antiplatelet and anticoagulanttherapy
    Christophe Hälg
    Department of Cardiology, University Hospital Basel, Basel, Switzerland
    EuroIntervention 5:425-31. 2009
    ..To assess major bleeding complications in patients after coronary stenting who are on dual antiplatelet drugs with or without oral anticoagulants...
  23. ncbi request reprint Anemia as independent predictor of major events in elderly patients with chronic angina
    Stefano Muzzarelli
    Division of Cardiology, University Hospital, Basel, Switzerland
    Am Heart J 152:991-6. 2006
    ..Therefore, we assessed the impact of anemia on long-term outcome in elderly patients with CAD...
  24. doi request reprint Drug-eluting versus bare-metal stents in large coronary arteries
    Christoph Kaiser
    Department of Cardiology, University Hospital, CH 4031 Basel, Switzerland
    N Engl J Med 363:2310-9. 2010
    ..We sought to confirm this observation and to assess whether this increase in risk was also seen with second-generation drug-eluting stents...
  25. ncbi request reprint Cost-effectiveness of drug-eluting stents in patients at high or low risk of major cardiac events in the Basel Stent KostenEffektivitäts Trial (BASKET): an 18-month analysis
    Hans Peter Brunner-La Rocca
    Department of Cardiology, University Hospital, Basel, Switzerland
    Lancet 370:1552-9. 2007
    ..Our aim was to determine whether drug-eluting stents are good value for money in long-term, everyday practice...
  26. ncbi request reprint Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial
    Paul Erne
    Division of Cardiology, Kantonsspital Luzern, Luzern, Switzerland
    JAMA 297:1985-91. 2007
    ..The effect of a percutaneous coronary intervention (PCI) on the long-term prognosis of patients with silent ischemia after a myocardial infarction (MI) is not known...
  27. ncbi request reprint Silent coronary artery disease in patients with diabetes mellitus
    M J Zellweger
    Department of Cardiology, University Hospital Basel, Switzerland
    Swiss Med Wkly 131:427-32. 2001
    ..Asymptomatic high-risk diabetic patients therefore might benefit from routine screening for silent ischaemia and risk stratification; furthermore, silent ischaemia has to be treated accordingly...
  28. pmc Coronary artery disease and outcome in acute congestive heart failure
    L Purek
    Department of Internal Medicine, University of Basel, University Hospital, Basel, Switzerland
    Heart 92:598-602. 2006
    ..To quantify the prognostic impact of coronary artery disease (CAD) on patients with acute heart failure (HF)...
  29. ncbi request reprint Limited diagnostic yield of non-invasive coronary angiography by 16-slice multi-detector spiral computed tomography in routine patients referred for evaluation of coronary artery disease
    Christoph Kaiser
    Division of Cardiology, University Hospital, CH 4031 Basel, Switzerland
    Eur Heart J 26:1987-92. 2005
    ..As no detailed comparative evaluation in consecutive patients referred for evaluation of CAD has been reported, this prospective study evaluating 2384 coronary segments in 149 consecutive patients was performed...
  30. ncbi request reprint Bedside quantification of atherosclerosis severity for cardiovascular risk stratification: a prospective cohort study
    Patrick R Hunziker
    Medical Intensive Care Unit, University Hospital, Basel, Switzerland
    J Am Coll Cardiol 39:702-9. 2002
    ..We sought to assess the ability of a new noninvasive method to quantify atherosclerosis severity and to examine its power to predict cardiovascular events...
  31. ncbi request reprint Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea
    Christian Mueller
    Department of Internal Medicine, Medical Division A, University of Basel, University Hospital, Basel, Switzerland
    N Engl J Med 350:647-54. 2004
    ..B-type natriuretic peptide levels are higher in patients with congestive heart failure than in patients with dyspnea from other causes...
  32. ncbi request reprint Troubleshooting for a stuck balloon-catheter
    Peter Matt
    Division of Cardiothoracic Surgery, University Hospital Basel, Basel, Switzerland
    Ann Thorac Surg 83:320. 2007
  33. doi request reprint Predictors of early readmission or death in elderly patients with heart failure
    Stefano Muzzarelli
    Department of Cardiology, University Hospital Basel, Basel, Switzerland
    Am Heart J 160:308-14. 2010
    ..Prior studies were focused on younger and less well-characterized patients. We aimed to identify predictors of early hospital readmission and death in elderly patients with HF...
  34. doi request reprint Comparative outcome one year after formal cardiac rehabilitation: the effects of a randomized intervention to improve exercise adherence
    Ines Arrigo
    Division of Cardiology, University Hospital, Basel, Switzerland
    Eur J Cardiovasc Prev Rehabil 15:306-11. 2008
    ..Methods to ensure sustained benefits of cardiac rehabilitation need to be explored. The aim was to assess the effect of a home-based intervention (INT) on exercise adherence and risk factors after cardiac rehabilitation...
  35. ncbi request reprint Usefulness of B-type natriuretic peptide and C-reactive protein in predicting the presence or absence of left ventricular hypertrophy in patients with systemic hypertension
    David Conen
    Department of Cardiology, University Hospital Basel, Basel, Switzerland
    Am J Cardiol 97:249-52. 2006
    ..In conclusion, in hypertensive patients, echocardiographic LV hypertrophy can be excluded on the basis of a single blood sample for the determination of BNP and CRP...
  36. ncbi request reprint Right atrial pacing impairs cardiac function during resynchronization therapy: acute effects of DDD pacing compared to VDD pacing
    Alain Bernheim
    Division of Cardiology, University Hospital, Basel, Switzerland
    J Am Coll Cardiol 45:1482-7. 2005
    ..We aimed to compare the hemodynamic effects of right-atrial-paced (DDD) and right-atrial-sensed (VDD) biventricular paced rhythm on cardiac resynchronization therapy (CRT)...
  37. ncbi request reprint Long-term performance of a simple algorithm for early discharge after ruling out acute coronary syndrome: a prospective multicenter trial
    Beat Andreas Schaer
    University Hospital, Petersgraben 4, CH 4031 Basel, Switzerland
    Chest 127:1364-70. 2005
    ..To test the short- and long-term performance of a simple algorithm to detect or rule out acute coronary artery disease (CAD) in patients referred with acute chest pain (CP)...
  38. ncbi request reprint Cell targeting by a generic receptor-targeted polymer nanocontainer platform
    Pavel Broz
    Medical Intensive Care Unit, University Hospital Basel, Petersgraben 4, Basel CH 4031, Switzerland
    J Control Release 102:475-88. 2005
    ..Low nonspecific binding supported the "stealth" properties of the carrier while cytotoxicity was absent. This versatile carrier appears promising for diagnostic or therapeutic medical use...
  39. ncbi request reprint Direct stenting with TAXUS stents seems to be as safe and effective as with predilatation. A post hoc analysis of TAXUS II
    Sigmund Silber
    Cardiology Practice and Hospital, Munich, Germany
    Herz 29:171-80. 2004
    ..While predilatation was recommended per protocol, direct stenting was not forbidden: thus, direct stenting was performed in 49 patients (TAXUS n = 23, control n = 26)...
  40. ncbi request reprint Correlates of one-year survival inpatients with cardiogenic shock complicating acute myocardial infarction: angiographic findings from the SHOCK trial
    Timothy A Sanborn
    Evanston Northwestern Healthcare, Evanston, Illinois 60201, USA
    J Am Coll Cardiol 42:1373-9. 2003
    ....
  41. ncbi request reprint Heart rate variability and cardiac troponin I are incremental and independent predictors of one-year all-cause mortality after major noncardiac surgery in patients at risk of coronary artery disease
    Miodrag Filipovic
    Department of Anesthesia, University of Basel Kantonsspital, Switzerland
    J Am Coll Cardiol 42:1767-76. 2003
    ....
  42. doi request reprint The balance of risks and benefits of drug-eluting versus bare-metal stents
    Matthias Pfisterer
    J Am Coll Cardiol 51:972; author reply 972-3. 2008
  43. ncbi request reprint Use of evidence-based medicine for acute coronary syndromes in the elderly and very elderly: insights from the Sibrafiban vs aspirin to Yield Maximum Protection from ischemic Heart events postacute cOroNary sYndromes trials
    Cheuk Kit Wong
    Cardiology, Dunedin School of Medicine, Otago University, Dunedin, New Zealand
    Am Heart J 154:313-21. 2007
    ..Evidence-based medications (EBM) are underused in older patients despite potentially larger absolute benefits. Little is known about factors influencing prescribing in the elderly with acute coronary syndromes...
  44. ncbi request reprint Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromes
    Darren K McGuire
    Donald W Reynolds Cardiovascular Clinical Research Center at the University of Texas Southwestern Medical Center, Dallas, Tex, USA
    Am Heart J 147:246-52. 2004
    ..The relative effect of glucose-lowering strategies of "insulin provision" versus "insulin sensitization" among patients with CAD remains unclear...
  45. ncbi request reprint Prognostic value of abnormal vasoreactivity of epicardial coronary arteries to sympathetic stimulation in patients with normal coronary angiograms
    Thomas H Schindler
    Division of Cardiology, Medical Clinic III, University Hospital of the Albert Ludwig University, Freiburg, Germany
    Arterioscler Thromb Vasc Biol 23:495-501. 2003
    ..We aimed to evaluate prospectively whether patients with normal coronary angiogram but abnormal epicardial vasoreactivity to cold pressor test (CPT) are at increased risk for cardiovascular events...
  46. ncbi request reprint [Increased rate of stent thrombosis with DES]
    Christoph Kaiser
    Abteilung Kardiologie, Universitatsspital Basel, Schweiz
    Herz 32:296-300. 2007
    ..In addition, new second-generation DES with a decreased risk for late stent thrombosis have to be developed...
  47. ncbi request reprint Coronary vasoregulation in patients with various risk factors in response to cold pressor testing: contrasting myocardial blood flow responses to short- and long-term vitamin C administration
    Thomas H Schindler
    Division of Cardiology and Nuclear Medicine, Medical Clinic III, University Hospital of the Albert Ludwig University, Freiburg, Germany
    J Am Coll Cardiol 42:814-22. 2003
    ....
  48. pmc Raised cardiac troponins
    Peter Ammann
    BMJ 328:1028-9. 2004
  49. ncbi request reprint Effects of anti-ischaemic drug therapy in silent myocardial ischaemia type I: the Swiss Interventional Study on Silent Ischaemia type I (SWISSI I): a randomized, controlled pilot study
    Paul Erne
    Kantonsspital, Luzern, Switzerland
    Eur Heart J 28:2110-7. 2007
    ..To determine the effect of anti-ischaemic drug therapy on long-term outcomes of asymptomatic patients without coronary artery disease (CAD) history but silent exercise ST-depression...